printer friendly version
Metabolic Syndrome and Insulin Resistance in Post-Liver Transplant Patients
Metabolic Syndrome (MS) is a condition related to insulin resistance and includes the combination of diabetes, hypertension, abnormal cholesterol, and obesity. Individual features of MS are common in post liver transplant patients. The purpose of the study is to determine how common metabolic syndrome is in those who undergo liver transplant and to see if there are associated features of developing MS in the post liver transplant setting.
Main Inclusion Criteria
Liver patients who are 18 years or older who have undergone a transplant between January 01, 2005 and June 30, 2008, who are at least 3 months post-liver transplant, regardless of the underlying cause of the liver disease.
Single Study Visit
- Usually during a regularly scheduled transplant clinic visit
- One time fasting blood draw, interview, and anthropometric measurements.
Note:
Labs billed to the patient or their insurer is comprehensive metabolic panel and cholesterol. If the patient is diabetic the hemoglobin A1C will be billed to the patient and/or insurer as part of standard of care for diabetic patients.
Labs sent to MDRTC is a storage sample and insulin and is funded by a GCRC grant.
Study Investigator: Hellan Kang, MD @ pager #14453, hellank@med.umich.edu, or 734-615-4628
Study Coordinator: Diane White, RRT @ pager #33042, dfwhite@med.umich.edu or 734-763-6647. |
